A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

Exclusion Criteria

• •Major organ system disease or clinical infection
• •Poorly controlled diabetes mellitus
• •Pregnant or lactating
• •Confluent, diffuse moccasin-type tinea pedis
• •Presence of onychomycosis involving a) more than 5 toe nails, b) any fingernail
• •Recent use of topical corticosteroids, topical antibiotics, or topical antifungal therapy to the foot
• •Recent use of systemic corticosteroids or antifungal therapy
• •Known(HIV)infection
• •Known significant hepatic, or hematologic impairment .Requirement for treatment with concomitant antimicrobial or systemic antifungal therapy for any reason.